A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
Clinical trial NCT05117476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05117476
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2026-03-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.